Matthew E. Colpoys, Jr. nominated to the Board of Directors
NeoDynamics Nomination Committee proposes Matt Colpoys as a new member of the Board. Matt Colpoys is an American with broad experience from the healthcare sector where he worked with orphan drugs and precision medicine. Today, Matt leverages his experience as a consultant for biotech and medical device companies, specializing in business development and commercialization. “With Matt, we bring in strong expertise from the US, which is a key market for NeoDynamics. He has contributed to a number of successful launches and deals in the sector. I look forward to welcoming him to the board,”